---
title: "US FDA approves ENGULF US pivotal trial of Hēlo thrombectomy system"
date: "2024-01-12T09:52:23.000Z"
publishedDate: "12 janvier 2024"
summary: "Endovascular Engineering (E2) has announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for its ENGULF US pivotal trial. The study will evaluate the safety and effectiveness of the Hēlo thrombectomy system in treating pulmonary embolism (PE)."
importance: ""
sourceUrl: "https://interventionalnews.com/us-fda-approves-engulf-us-pivotal-trial-of-helo-thrombectomy-system/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-01-12-us-fda-approves-engulf-us-pivotal-trial-of-helo-thrombectomy-system"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2020/03/Generic-innovation.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/us-fda-approves-engulf-us-pivotal-trial-of-helo-thrombectomy-system/"
---

![US FDA approves ENGULF US pivotal trial of Hēlo thrombectomy system](https://interventionalnews.com/wp-content/uploads/sites/13/2020/03/Generic-innovation.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/us-fda-approves-engulf-us-pivotal-trial-of-helo-thrombectomy-system/*

## L’essentiel

Endovascular Engineering (E2) has announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for its ENGULF US pivotal trial. The study will evaluate the safety and effectiveness of the Hēlo thrombectomy system in treating pulmonary embolism (PE).

## Lien source

https://interventionalnews.com/us-fda-approves-engulf-us-pivotal-trial-of-helo-thrombectomy-system/
